A Community Screening Program for Helicobacter pylori Saves Money: 10-Year Follow-up of a Randomized Controlled Trial
Tài liệu tham khảo
Ferlay, 2004
2001, Gastric cancer and Helicobacter pylori, Gut, 49, 347, 10.1136/gut.49.3.347
Moayyedi, 1997, Helicobacter pylori and gastric cancer, Gastrointest Endosc Clin N Am, 7, 47, 10.1016/S1052-5157(18)30322-2
Wong, 2004, Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China, JAMA, 291, 187, 10.1001/jama.291.2.187
Parsonnet, 2004, Helicobacter pylori infection and gastric cancer—for want of more outcomes, JAMA, 291, 244, 10.1001/jama.291.2.244
Megraud, 1997, How should Helicobacter pylori infection be diagnosed?, Gastroenterology, 113, S93, 10.1016/S0016-5085(97)80020-0
Ford, 2003, How can current strategies for Helicobacter pylori eradication therapy be improved?, Can J Gastroenterol, 17, b36, 10.1155/2003/714124
Kuipers, 1993, Seroconversion for Helicobacter pylori, Lancet, 342, 10.1016/0140-6736(93)91473-Y
Parsonnet, 1996, Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer, Lancet, 348, 150, 10.1016/S0140-6736(96)01501-2
Sonnenberg, 1998, Medical decision models of Helicobacter pylori therapy to prevent gastric cancer, Aliment Pharmacol Ther, 12, S111, 10.1111/j.1365-2036.1998.00001.x
Ford, 2004, Eradication therapy in Helicobacter pylori positive peptic ulcer disease, Am J Gastroenterol, 99, 1833, 10.1111/j.1572-0241.2004.40014.x
Moayyedi, 2003, An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in non-ulcer dyspepsia, Am J Gastroenterol, 98, 2621, 10.1111/j.1572-0241.2003.08724.x
Moayyedi, 2000, Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community, Lancet, 355, 1665, 10.1016/S0140-6736(00)02236-4
Mason, 2002, The cost-effectiveness of population Helicobacter pylori screening and treatment, Aliment Pharmacol Ther, 16, 559, 10.1046/j.1365-2036.2002.01204.x
Moayyedi, 1998, The Leeds Dyspepsia Questionnaire, Aliment Pharmacol Ther, 12, 1257, 10.1046/j.1365-2036.1998.00404.x
NHS reference costs 2002. Department of Health. Available at: http://www.dh.gov.uk/Home/fs/en. Accessed January 31, 2004.
The British National Formulary number 46, September 2003. Available at: http://www.bnf.org/bnf. Accessed April 12, 2005.
Fraser, 2003, Validation of the short-form Leeds dyspepsia questionnaire (SF-LDQ) in a community setting, Gastroenterology, 124, A224, 10.1016/S0016-5085(03)81126-5
Moayyedi, 2002, Clinical and economic consequences of dyspepsia in the community, Gut, 50, 10